Stock Deletions 02/28/2019
02/28/2019 INTHY InTouch
Stock Deletions 02/28/2019
02/28/2019 INTHY InTouch Holdings Pub. Co., Ltd. American Depository Receipts Pink Current Deleted ADR/GDR Program Terminated
02/28/2019 GNNT Cannabis Suisse Corp. Common Stock Pink Current Deleted 20:1 F/S
02/28/2019 FQFC Fuquan Financial Company Common Stock Pink Current Deleted 1:4 R/S
02/28/2019 ESES "Eco Stim Energy Solutions Inc." Common Stock Pink Current Deleted 1:4 R/S
02/28/2019 CVHIF Ventura Cannabis and Wellness Corp. Ordinary Shares Pink Current Deleted 1:7.34 R/S
02/28/2019 CRRCF CREDIT SUISSE AG (Nassau Branch) Common Stock Grey Market Deleted Security became Matured/Expired
02/28/2019 BTOP Pulse Evolution Group, Inc. Common Stock OTCQB Deleted 1:30
02/28/2019 ACCCY Accton Technology Corp. American Depository Receipts Grey Market Deleted ADR/GDR Program Terminated
02/28/2019 ACCCF Accton Technology Corp. Global Depository Receipts Grey Market Deleted ADR/GDR Program Terminated
02/27/2019 TLP TransMontaigne Partners LP Units No Tier Deleted Merger
02/27/2019 OSKGF Osisko Gold Royalties Ltd. Warrants Grey Market Deleted Security became Matured/Expired
02/27/2019 MLGCF ML Gold Corp. Ordinary Shares OTCQB Deleted "1:10 R/S; Matching TSX Ex date"
02/27/2019 IMGKY Imaginatik Plc. American Depository Receipts Grey Market Deleted ADR/GDR Program Terminated
02/27/2019 BAPUF Banpu Public Co., Ltd. Ordinary Shares Grey Market Reactivated
02/26/2019 TVZIF Technovator International Ltd. Ordinary Shares Grey Market Reactivated
02/26/2019 TBNAF Tachibana Shokai Ltd Ordinary Shares Grey Market Deleted Inactive Security
02/26/2019 STMC Smart SMS Corp. Common Stock Grey Market Deleted Inactive Security
02/26/2019 MHTUF Merchants Trust Plc Ordinary Shares Grey Market Deleted Inactive Security
02/26/2019 MGABY Megabank Plc American Depository Receipts Grey Market Deleted ADR/GDR Program Terminated
02/26/2019 GTIJY Guotai Junan International Holdings Ltd. American Depository Receipts Grey Market Deleted ADR/GDR Program Terminated
02/26/2019 GENRF Global Energy Resources International Group, Ltd. Ordinary Shares Grey Market Deleted Inactive Security
02/26/2019 CHOLY China Oilfield Services Ltd. American Depository Receipts Pink Current Deleted ADR/GDR Program Terminated
02/26/2019 BVAXF Biondvax Pharmaceuticals Ltd Ordinary Shares Grey Market Deleted Inactive Security
02/25/2019 XSPA XpresSpa Group, Inc. Common Stock No Tier Deleted 1:20 R/S
02/25/2019 NDWTF NETDRAGON WEBSOFT HLDGS LTD Ordinary Shares Grey Market Reactivated
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...
Continue Reading
Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...
Continue Reading
Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...
Continue Reading
Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...
Continue Reading
Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...
Continue Reading
Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...
Continue Reading
Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....
Continue Reading
Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...
Continue Reading
Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...
Continue Reading
NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...
Continue Reading
Top 5 Most Recently Viewed Articles
EP3 Technology Powers Transformative Election Insights ForecastEx, a dynamic subsidiary of Interactive Brokers (IBKR), achieved a remarkable feat by processing over $560 million in election contracts during the 2024 U.S. general election. The groundbreaking technology enabling this achievement is Connamara Technologies' EP3 matching engine, an innovative platform designed...
Continue Reading
Transforming a Chicago Landmark into a Modern Data Center The historic 300,500 square foot building located at 400 S. LaSalle Street, once the home of the Chicago Board Options Exchange, is set to undergo an exciting transformation. Through an acquisition announced recently, GI Partners and Legacy Investing, LLC have acquired this prominent property with the intention of...
Continue Reading
Radiotherapy Market's Projected Growth: What's Fueling It? It's no secret: the radiotherapy market is on an upward trajectory, heading toward a substantial $10.68 billion valuation by 2031. But what’s pushing this rocket? For starters, we’re looking at a steady compound annual growth rate (CAGR) of 6.0% from 2026 to 2031. Not too shabby in today’s volatile economic...
Continue Reading
Take Action: Class Action Against Newmont Corporation Levi & Korsinsky, LLP is reaching out to investors linked to Newmont Corporation, urging them to act before the April 1, 2025 deadline for joining a class action lawsuit. This lawsuit addresses alleged securities fraud that negatively impacted many of Newmont's investors. Understanding the Class Action The class action...
Continue Reading
InflaRx Unveils New Developments for INF904 InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company recognized for its innovative anti-inflammatory therapies targeting the complement system, has recently shared promising preclinical results for its oral C5aR inhibitor, INF904. This announcement took place at the 2024 European Meeting on Complement in Human Diseases...
Continue Reading